We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$8.5B
AUM Growth
+$1.06B
Cap. Flow
+$740M
Cap. Flow %
8.7%
Top 10 Hldgs %
20.59%
Holding
2,213
New
217
Increased
1,136
Reduced
703
Closed
106

Sector Composition

Rank Sector Weight
1 Technology 5.27%
2 Financials 4.79%
3 Healthcare 4%
4 Industrials 3.92%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTE icon
2051
Baytex Energy
BTE
$3.07B
$60K ﹤0.01%
20,026
-140
-0.7% -$412
DALN
2052
DELISTED
DallasNews
DALN
$60K ﹤0.01%
3,100
-325
-9% -$6.17K
FCSC
2053
DELISTED
Fibrocell Science Inc.
FCSC
$60K ﹤0.01%
18,618
+5,058
+37% +$44.2K
WFT
2054
DELISTED
Weatherford International plc
WFT
$59K ﹤0.01%
14,152
+1,788
+14% +$6.59K
PER
2055
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$58K ﹤0.01%
28,335
-12,457
-31% -$32.8K
EGC
2056
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
$58K ﹤0.01%
+10,050
New +$70.8K
QMCO icon
2057
Quantum Corp
QMCO
$457M
$57K ﹤0.01%
+504
New +$54.2K
MEET
2058
DELISTED
The Meet Group, Inc. Common Stock
MEET
$56K ﹤0.01%
19,741
-3,004
-13% -$8.94K
WPRT
2059
Westport Fuel Systems
WPRT
$36.5M
$54K ﹤0.01%
1,436
+362
+34% +$11.8K
MNKD icon
2060
MannKind Corp
MNKD
$1.26B
$52K ﹤0.01%
22,320
-2,073
-8% -$7.08K
HL icon
2061
Hecla Mining
HL
$11.7B
$51K ﹤0.01%
12,807
-21,051
-62% -$91.5K
INO icon
2062
Inovio Pharmaceuticals
INO
$73M
$46K ﹤0.01%
925
+90
+11% +$5.58K
PLUG icon
2063
Plug Power
PLUG
$2.93B
$43K ﹤0.01%
18,231
+995
+6% +$2.55K
BAC.WS.B
2064
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$43K ﹤0.01%
20,000
HOV icon
2065
Hovnanian Enterprises
HOV
$764M
$40K ﹤0.01%
474
NAVB
2066
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$40K ﹤0.01%
5,549
+3,911
+239% +$33.1K
ARWR icon
2067
Arrowhead Research
ARWR
$12.5B
$39K ﹤0.01%
10,600
SDLP
2068
DELISTED
SEADRILL PARTNERS LLC
SDLP
$39K ﹤0.01%
1,065
ACGN
2069
DELISTED
Aceragen Inc
ACGN
$38K ﹤0.01%
132
XTNT icon
2070
Xtant Medical Holdings
XTNT
$61.8M
$37K ﹤0.01%
5,357
UQM
2071
DELISTED
UQM Technologies, Inc.
UQM
$36K ﹤0.01%
26,114
ALIM
2072
DELISTED
Alimera Sciences
ALIM
$32K ﹤0.01%
+1,587
New +$31K
TLPH icon
2073
Talphera
TLPH
$73.7M
$30K ﹤0.01%
734
+135
+23% +$6.59K
CGEN icon
2074
Compugen
CGEN
$220M
$29K ﹤0.01%
11,575
-2,000
-15% -$5.95K
PLM
2075
DELISTED
PolyMet Mining Corp.
PLM
$29K ﹤0.01%
3,359

Similar funds

Cambridge Investment Research Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Cambridge Investment Research Advisors held 2,213 positions worth $8.5B, up 14% from $7.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $740M of net new capital in Q4 2017, opening 217 new positions and adding to 1,136 existing holdings. Its largest new stake was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 445,407 shares worth $13.7M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $12.9M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2017 buy was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 445,407 shares worth $13.7M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2017 reduction was iShares US Real Estate ETF, cutting an estimated $12.9M.
  • Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q4 2017, selling an estimated $5.38M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $8.5B portfolio in Q4 2017.
  • Cambridge Investment Research Advisors opened 217 new positions and closed 106 in Q4 2017.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $8.5B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2017, filed 22 Feb 2018.